Drug phototoxic response
ICD-10 L56.0 is a billable code used to indicate a diagnosis of drug phototoxic response.
L56.0 refers to drug phototoxic response, a skin reaction that occurs when certain medications are taken and the skin is subsequently exposed to sunlight. This condition is characterized by an exaggerated sunburn-like reaction, which can manifest as erythema, edema, and blistering in areas exposed to UV light. The anatomy involved primarily includes the epidermis and dermis, where the phototoxic reaction occurs due to the interaction between the drug and UV radiation. Common drugs associated with phototoxic responses include certain antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and some chemotherapeutic agents. Disease progression typically begins with an initial exposure to the drug followed by UV light, leading to symptoms that can appear within hours to days. Diagnostic considerations include a thorough patient history, identification of the offending drug, and clinical examination of the skin lesions. Patch testing may also be utilized to confirm the diagnosis. It is essential for healthcare providers to recognize this condition to prevent further exposure and manage symptoms effectively.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L56.0 covers drug-induced phototoxic responses, which can include conditions such as phototoxic dermatitis and acute sunburn-like reactions due to specific medications. It is essential to identify the drug responsible for the reaction to manage the condition effectively.
L56.0 should be used when the skin reaction is specifically due to a drug and exacerbated by sunlight exposure. It is important to differentiate it from L56.1, which pertains to photoallergic reactions that involve an immune response.
Documentation should include a detailed patient history, identification of the drug involved, clinical findings of the skin reaction, and any relevant laboratory tests or patch testing results that support the diagnosis of a drug phototoxic response.
